Simvastatin is used to lower cholesterol and reduce the risk of heart disease and stroke by helping your body produce less cholesterol and break down cholesterol that's already in your blood.[2] Zocor is currently approved and in use across 155 indications[4].[1]
Zocor is one of 2689 small molecule programs targeting Acute Pancreatitis. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Patents
Pipeline
Competition
2828 competitors in Breast Cancer
Zocor
Adriamycin
Nolvadex
MS Contin
Zolymbus
Effexor
Tricor
Chirocaine
Vfend
Paracetamol
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Dec 23, 1991
ZOCOR
NDA NDA019766
Oct 9, 2007
SIMVASTATIN
NDA NDA021961
Apr 21, 2016
FLOLIPID
NDA NDA206679
Sources
Details